Fractyl Health to Participate in Upcoming September Investor Conferences
Fractyl Health (Nasdaq: GUTS), a metabolic therapeutics company focusing on obesity and Type 2 Diabetes treatments, has announced its participation in two upcoming investor conferences. Dr. Harith Rajagopalan, Co-founder and CEO, will represent the company at these events:
1. Morgan Stanley Global Healthcare Conference on 09/06/2024 at 10:45 AM ET (Fireside Chat format)
2. H.C. Wainwright 26th Annual Global Investment Conference on 09/09/2024 at 2:00 PM ET (Company Presentation format)
Webcast replays will be available on the company's investor relations website after the live sessions.
Fractyl Health (Nasdaq: GUTS), un'azienda specializzata in terapie metaboliche focalizzate sui trattamenti per obesità e diabete di tipo 2, ha annunciato la sua partecipazione a due prossime conferenze per investitori. Dr. Harith Rajagopalan, co-fondatore e CEO, rappresenterà l'azienda in questi eventi:
1. Conferenza Globale sulla Salute di Morgan Stanley il 06/09/2024 alle 10:45 AM ET (formato Fireside Chat)
2. 26° Conferenza Globale Annuale sugli Investimenti di H.C. Wainwright il 09/09/2024 alle 2:00 PM ET (formato Presentazione Aziendale)
Le registrazioni delle webcast saranno disponibili sul sito web delle relazioni con gli investitori dell'azienda dopo le sessioni dal vivo.
Fractyl Health (Nasdaq: GUTS), una empresa de terapias metabólicas enfocada en tratamientos para obesidad y diabetes tipo 2, ha anunciado su participación en dos próximas conferencias para inversores. Dr. Harith Rajagopalan, cofundador y CEO, representará a la empresa en estos eventos:
1. Conferencia Global de Salud de Morgan Stanley el 06/09/2024 a las 10:45 AM ET (formato Fireside Chat)
2. 26ª Conferencia Global Anual de Inversiones de H.C. Wainwright el 09/09/2024 a las 2:00 PM ET (formato Presentación de la Empresa)
Las reproducciones de la transmisión estarán disponibles en el sitio web de relaciones con los inversores de la empresa después de las sesiones en vivo.
Fractyl Health (Nasdaq: GUTS)은 비만 및 제2형 당뇨병 치료에 중점을 둔 대사 치료 회사로, 두 개의 다가오는 투자자 회의에 참여할 것이라고 발표했습니다. Harith Rajagopalan 박사가 이 이벤트에서 회사를 대표합니다:
1. 모건 스탠리 글로벌 헬스케어 컨퍼런스 2024년 9월 6일 오전 10:45 ET (Fireside Chat 형식)
2. H.C. 웨인라이트 제26회 글로벌 투자 컨퍼런스 2024년 9월 9일 오후 2시 ET (회사 발표 형식)
웹캐스트 다시 보기는 실시간 세션 종료 후 회사의 투자자 관계 웹사이트에서 이용할 수 있습니다.
Fractyl Health (Nasdaq: GUTS), une entreprise de thérapies métaboliques axée sur les traitements de l'obésité et du diabète de type 2, a annoncé sa participation à deux prochaines conférences pour investisseurs. Dr. Harith Rajagopalan, co-fondateur et PDG, représentera l'entreprise lors de ces événements :
1. Conférence Mondiale sur la Santé de Morgan Stanley le 06/09/2024 à 10h45 ET (format Fireside Chat)
2. 26ème Conférence Globale Annuelle sur les Investissements de H.C. Wainwright le 09/09/2024 à 14h00 ET (format Présentation de l'Entreprise)
Les rediffusions des webcasts seront disponibles sur le site Web des relations avec les investisseurs de l'entreprise après les sessions en direct.
Fractyl Health (Nasdaq: GUTS), ein Unternehmen für metabolische Therapeutika, das sich auf Fettleibigkeit und Typ-2-Diabetes-Behandlungen spezialisiert hat, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen bekannt gegeben. Dr. Harith Rajagopalan, Mitbegründer und CEO, wird das Unternehmen bei diesen Veranstaltungen vertreten:
1. Morgan Stanley Global Healthcare Conference am 06.09.2024 um 10:45 Uhr ET (Fireside Chat-Format)
2. H.C. Wainwright 26. Jahreskonferenz für globale Investitionen am 09.09.2024 um 14:00 Uhr ET (Unternehmenspräsentationsformat)
Die Wiederholungen der Webcasts werden nach den Live-Sitzungen auf der Investor-Relations-Website des Unternehmens verfügbar sein.
- None.
- None.
BURLINGTON, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on pioneering new approaches that treat root causes of obesity and Type 2 Diabetes (T2D), today announced that Harith Rajagopalan, M.D., Ph.D., Co-founder and Chief Executive Officer of the Company, will present at two upcoming investor conferences.
Details of the presentations can be found below.
Morgan Stanley Global Healthcare Conference
Format: Fireside Chat
Date: 09/06/2024
Time: 10:45 AM ET
H.C. Wainwright 26th Annual Global Investment Conference
Format: Company Presentation
Date: 09/09/2024
Time: 2:00 PM ET
Webcast replays will be accessible following the live sessions on the Events page of the Investors section on the Company’s website at https://ir.fractyl.com/.
About Fractyl Health
Fractyl Health is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including obesity and T2D. Despite advances in treatment over the last 50 years, obesity and T2D continue to be rapidly growing drivers of morbidity and mortality in the 21st century. Fractyl Health’s goal is to transform metabolic disease treatment from chronic symptomatic management to durable disease-modifying therapies that target the organ-level root causes of disease. Fractyl Health is based in Burlington, MA. For more information, visit www.fractyl.com or https://twitter.com/FractylHealth.
Contacts
Corporate Contact
Lisa Davidson, Chief Financial Officer
ir@fractyl.com, 781.902.8800
Media Contact
Jessica Cotrone, Corporate Communications
jcotrone@fractyl.com, 978.760.5622
Investor Contact
Stephen Jasper, Gilmartin Group
stephen@gilmartinir.com, 619.949.3681
FAQ
What investor conferences will Fractyl Health (GUTS) participate in during September 2024?
Who will represent Fractyl Health (GUTS) at the upcoming investor conferences?
What is the format of Fractyl Health's (GUTS) presentation at the Morgan Stanley Global Healthcare Conference?
When is Fractyl Health (GUTS) scheduled to present at the H.C. Wainwright Global Investment Conference?
How can investors access the webcast replays of Fractyl Health's (GUTS) conference presentations?
